- Home
- Publications
- Publication Search
- Publication Details
Title
Potential Therapeutic Targets of B7 Family in Colorectal Cancer
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-05-05
DOI
10.3389/fimmu.2020.00681
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1
- (2019) Chu-Yu Jing et al. Journal for ImmunoTherapy of Cancer
- Immunotherapy in colorectal cancer: rationale, challenges and potential
- (2019) Karuna Ganesh et al. Nature Reviews Gastroenterology & Hepatology
- B7-H3 immune checkpoint protein in human cancer
- (2019) Karine Flem-Karlsen et al. CURRENT MEDICINAL CHEMISTRY
- B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2
- (2019) Tongguo Shi et al. Cell Death & Disease
- Hypoxia-induced VISTA promotes the suppressive function of myeloid- derived suppressor cells in the tumor microenvironment
- (2019) Jie Deng et al. Cancer Immunology Research
- Analysis of VISTA expression and function in renal cell carcinoma highlights VISTA as a potential target for immunotherapy
- (2019) Shanjuan Hong et al. Protein & Cell
- Immune checkpoint protein VISTA regulates antitumor immunity by controlling myeloid cell-mediated inflammation and immunosuppression
- (2019) Wenwen Xu et al. Cancer Immunology Research
- Prognostic Significance of Potential Immune Checkpoint Member HHLA2 in Human Tumors: A Comprehensive Analysis
- (2019) Ben Wang et al. Frontiers in Immunology
- Tumor-expressed B7-H3 mediates the inhibition of antitumor T-cell functions in ovarian cancer insensitive to PD-1 blockade therapy
- (2019) Dongli Cai et al. Cellular & Molecular Immunology
- Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups
- (2019) Lawrence P. Andrews et al. NATURE IMMUNOLOGY
- Wide Expression and Significance of Alternative Immune Checkpoint Molecules, B7x and HHLA2, in PD-L1–Negative Human Lung Cancers
- (2018) Haiying Cheng et al. CLINICAL CANCER RESEARCH
- B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity
- (2018) Kimio Yonesaka et al. CLINICAL CANCER RESEARCH
- Recent Advances in the Clinical Development of Immune Checkpoint Blockade Therapy for Mismatch Repair Proficient (pMMR)/non-MSI-H Metastatic Colorectal Cancer
- (2018) James J. Lee et al. Clinical Colorectal Cancer
- Correlation of IDH1 and B7 H3 expression with prognosis of CRC patients
- (2018) Jingyi Wu et al. EJSO
- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
- (2018) Michael J. Overman et al. JOURNAL OF CLINICAL ONCOLOGY
- Upregulated immune checkpoint HHLA2 in clear cell renal cell carcinoma: a novel prognostic biomarker and potential therapeutic target
- (2018) Dongming Chen et al. JOURNAL OF MEDICAL GENETICS
- Genomics and emerging biomarkers for immunotherapy of colorectal cancer
- (2018) Jakob Nikolas Kather et al. SEMINARS IN CANCER BIOLOGY
- Overexpression of HHLA2, a member of the B7 family, is associated with worse survival in human colorectal carcinoma
- (2018) Ziwen Zhu et al. OncoTargets and Therapy
- The association of human endogenous retrovirus-H long terminal repeat-associating protein 2 (HHLA2) expression with gastric cancer prognosis
- (2018) Masataka Shimonosono et al. Oncotarget
- The comprehensive molecular landscape of the immunologic co-stimulator B7 and TNFR ligand receptor families in colorectal cancer: immunotherapeutic implications with microsatellite instability
- (2018) Jinghua Tang et al. OncoImmunology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Expression of the inhibitory B7 family molecule VISTA in human colorectal carcinoma tumors
- (2018) Shan Xie et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- VSIG-3 as a ligand of VISTA inhibits human T cell function
- (2018) Jinghua Wang et al. IMMUNOLOGY
- HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival
- (2018) Han Yan et al. CANCER LETTERS
- The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3
- (2017) Murali Janakiram et al. IMMUNOLOGICAL REVIEWS
- Immunoregulatory functions of VISTA
- (2017) Elizabeth C. Nowak et al. IMMUNOLOGICAL REVIEWS
- New checkpoints in cancer immunotherapy
- (2017) Ling Ni et al. IMMUNOLOGICAL REVIEWS
- Selective blockade of B7-H3 enhances antitumour immune activity by reducing immature myeloid cells in head and neck squamous cell carcinoma
- (2017) Liang Mao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Cancer cell‑expressed B7‑H3 regulates the differentiation of tumor‑associated macrophages in human colorectal carcinoma
- (2017) Yong Mao et al. Oncology Letters
- Targeting T Cell Co-receptors for Cancer Therapy
- (2016) Margaret K. Callahan et al. IMMUNITY
- B7-H3 upregulates BRCC3 expression, antagonizing DNA damage caused by 5-Fu
- (2016) ZHANG ZHANG SUN et al. ONCOLOGY REPORTS
- The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer
- (2016) Bo Jiang et al. Oncotarget
- HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival
- (2016) Pratistha Koirala et al. Scientific Reports
- A New B7:CD28 Family Checkpoint Target for Cancer Immunotherapy: HHLA2
- (2015) Y. Xiao et al. CLINICAL CANCER RESEARCH
- B7-H3 promotes cell migration and invasion through the Jak2/Stat3/MMP9 signaling pathway in colorectal cancer
- (2015) FEN LIU et al. Molecular Medicine Reports
- Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses
- (2015) Jun Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3
- (2015) Ting Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 families
- (2015) Murali Janakiram et al. OncoImmunology
- B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome
- (2014) Vibeke A Ingebrigtsen et al. BMC CANCER
- VISTA Is an Immune Checkpoint Molecule for Human T Cells
- (2014) J. L. Lines et al. CANCER RESEARCH
- Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein
- (2014) M. Janakiram et al. CLINICAL CANCER RESEARCH
- Coinhibitory receptor PD-1H preferentially suppresses CD4+ T cell–mediated immunity
- (2014) Dallas B. Flies et al. JOURNAL OF CLINICAL INVESTIGATION
- Overexpression of B7-H3 in CD133+ colorectal cancer cells is associated with cancer progression and survival in human patients
- (2014) Zhou Bin et al. JOURNAL OF SURGICAL RESEARCH
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function
- (2013) R. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- B7-H5 costimulates human T cells via CD28H
- (2013) Yuwen Zhu et al. Nature Communications
- Effects of B7-H3 on the Inflammatory Response and Expression of MMP-9 in Mice with Pneumococcal Meningitis
- (2012) Xuqin Chen et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Identification of IGPR-1 as a novel adhesion molecule involved in angiogenesis
- (2012) Nader Rahimi et al. MOLECULAR BIOLOGY OF THE CELL
- Costimulatory Protein 4IgB7H3 Drives the Malignant Phenotype of Glioblastoma by Mediating Immune Escape and Invasiveness
- (2011) D. Lemke et al. CLINICAL CANCER RESEARCH
- VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
- (2011) Li Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma
- (2010) Jing Sun et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Peripheral blood gene expression of B7 and CD28 family members associated with tumor progression and microscopic lymphovascular invasion in colon cancer patients
- (2010) Hyunji Lee et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction
- (2009) Judith Leitner et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation